慢性肾衰竭患者使用肾康注射液现状分析.docVIP

西安医学院药学院本科学位论文 慢性肾衰竭患者使用肾康注射液的现状分析 摘要：目的 了解慢性肾衰竭患者使用肾康注射液的临床现状，为规范临床合理用药提供参考和借鉴。方法 采用回顾性分析方法，筛选陕西省人民医院HIS系统中2013年12月～2014年3月使用肾康注射液的慢性肾衰竭患者群信息，主要包括：基本信息、费用信息、肾康注射液应用情况、出院诊断、合并用药情况；采用EXCEL、SPSS 21软件进行信息收集和统计学分析，整合患者信息分布情况，结合药品说明书判断肾康注射液使用及合并用药的合理性。结果 在HIS数据库中使用肾康注射液的慢性肾衰患者的平均年龄为59.5±15.4岁；男性比例大于女性；住院天数集中在8～14d；出院情况多为好转；给药剂量、给药途径基本符合药品说明书；出院诊断除肾脏疾病外，主要合并有肾性贫血、肾性高血压、糖尿病；慢性肾衰竭患者使用肾康注射液时常与心脑血管系统药物、泌尿系统药物、抗贫血药、钙调节剂合并使用。结论 使用肾康注射液的慢性肾衰竭人群以中老年人居多；临床使用基本符合药品说明书的相关规定；部分患者存在联合用药不当或溶媒选择不当等用药不适宜现象。建议临床医生在使用药品时重视说明书在医疗安全中的指导作用，更仔细研读说明书内容，保证临床用药的安全合理。 关键词：医院信息管理系统；肾康注射液；慢性肾衰竭 Clinical outcomes of parenterally administered Shenkang injection analysis of hospital information system data ABSTRACT: OBJECTIVE Hospital information system data of chronic renal failure (CRF) patients who received parenterally administered Shenkang injection was analyzed. This provided guide of the efficacy and safety of ShengKang injection in the treatment of chronic renal failure. METHODS In this paper, HIS data form ShanXi province people hospital was analyzed. Patients receiving with parenteration administered Shenkang injection for treatment of CRF were included from December 2013 to March 2014. Information on basic information, costs, application, diagnosis and drug combination. The information were collected by EXCEL and were made the statistics by SPSS 21. Combined with drugs instruction discuss application and the rationality of drug combination. RESULTS The average age of patients was 59±15.41 years old. Days of hospitalization ranged form 8 to 14 days. The majority of therapeutic effect is make a improvement. Drug delivery dosage, dosing way are conforms with instructions basically. The most commonly used in combination with Shenkang injection were: cardiovascular system drugs, urinary system drug, antianemic agents and calcium regulating agent. CONCLUSION CRF patients using parenterally administered Shenkang injection were a mostly elderly population，with an average age of 59.5±15.4．Alt